LEGN
Price:
$32.8
Market Cap:
$6.02B
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comparison of the treatment with standard triplet therapy in revlimid-refractory multiple myeloma. The company also has a portfolio of earlier-stage autologous product candidates, which are in Phase I clinical trials for the treatment of gastric cancer and T cell lymphoma. In addition, it is developing CAR-T product candid...[Read more]
Industry
Biotechnology
IPO Date
2020-06-05
Stock Exchange
NASDAQ
Ticker
LEGN
According to Legend Biotech Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 5.90B. This represents a change of -16.47% compared to the average of 7.07B of the last 4 quarters.
The mean historical Enterprise Value of Legend Biotech Corporation over the last ten years is 5.59B. The current 5.90B Enterprise Value has changed 10.46% with respect to the historical average. Over the past ten years (40 quarters), LEGN's Enterprise Value was at its highest in in the November 2022 quarter at 15.35B. The Enterprise Value was at its lowest in in the September 2024 quarter at -112686000.00.
Average
5.59B
Median
4.88B
Minimum
2.87B
Maximum
9.65B
Discovering the peaks and valleys of Legend Biotech Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 108.68%
Maximum Annual Enterprise Value = 9.65B
Minimum Annual Increase = -40.19%
Minimum Annual Enterprise Value = 2.87B
Year | Enterprise Value | Change |
---|---|---|
2023 | 9.65B | 29.69% |
2022 | 7.44B | 23.98% |
2021 | 6.00B | 108.68% |
2020 | 2.87B | -40.19% |
2019 | 4.81B | 37.57% |
2018 | 3.49B | -28.43% |
The current Enterprise Value of Legend Biotech Corporation (LEGN) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
7.69B
5-year avg
6.15B
10-year avg
5.59B
Legend Biotech Corporation’s Enterprise Value is less than Vaxcyte, Inc. (9.69B), greater than Apellis Pharmaceuticals, Inc. (4.22B), greater than Travere Therapeutics, Inc. (1.86B), greater than Akero Therapeutics, Inc. (1.71B), greater than IVERIC bio, Inc. (5.13B), less than Blueprint Medicines Corporation (6.13B), greater than Amylyx Pharmaceuticals, Inc. (204.92M), less than Karuna Therapeutics, Inc. (12.43B), greater than Day One Biopharmaceuticals, Inc. (857.57M), greater than Zai Lab Limited (2.45B), less than Seagen Inc. (42.84B), less than Alnylam Pharmaceuticals, Inc. (31.58B), less than Ascendis Pharma A/S (8.13B), greater than 89bio, Inc. (879.76M), less than Madrigal Pharmaceuticals, Inc. (6.69B), greater than Pliant Therapeutics, Inc. (801.51M), greater than Arcellx, Inc. (4.10B), greater than Stoke Therapeutics, Inc. (451.87M), greater than Mirati Therapeutics, Inc. (3.91B), greater than Terns Pharmaceuticals, Inc. (223.81M),
Company | Enterprise Value | Market cap |
---|---|---|
9.69B | $10.71B | |
4.22B | $4.14B | |
1.86B | $1.49B | |
1.71B | $1.99B | |
5.13B | $5.51B | |
6.13B | $5.75B | |
204.92M | $274.19M | |
12.43B | $12.60B | |
857.57M | $1.28B | |
2.45B | $2.93B | |
42.84B | $43.15B | |
31.58B | $31.37B | |
8.13B | $8.29B | |
879.76M | $933.60M | |
6.69B | $6.80B | |
801.51M | $820.92M | |
4.10B | $4.20B | |
451.87M | $599.59M | |
3.91B | $4.12B | |
223.81M | $492.65M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Legend Biotech Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Legend Biotech Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Legend Biotech Corporation's Enterprise Value?
What is the highest Enterprise Value for Legend Biotech Corporation (LEGN)?
What is the 3-year average Enterprise Value for Legend Biotech Corporation (LEGN)?
What is the 5-year average Enterprise Value for Legend Biotech Corporation (LEGN)?
How does the current Enterprise Value for Legend Biotech Corporation (LEGN) compare to its historical average?